Phase 3 Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus Interventions: Drug: TG103; Drug: Dulaglutide Sponsors: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials